Investing.com -- The Department of Health and Human Services (HHS), under the leadership of Robert F. Kennedy Jr., is set to discontinue the Centers for Disease Control and Prevention’s (CDC) recommendations for routine Covid-19 vaccines for pregnant women, teenagers, and children. The exact date of this announcement is yet to be confirmed, but it is expected in the upcoming days, according to The Wall Street Journal.
Currently, the CDC advises everyone aged six months and older, including pregnant women, to receive the Covid-19 vaccines. It remains uncertain whether HHS plans to completely remove the recommendation for Covid-19 vaccinations for these groups, or if it will suggest patients discuss the risks and benefits with their doctors.
Simultaneously, the Food and Drug Administration (FDA) is developing a new framework for vaccine approval, potentially demanding more data from pharmaceutical companies, including placebo testing for all new vaccines.
This shift in Covid-19 vaccination policy could lead to a decrease in the number of vaccinations, affecting insurance coverage and reversing Operation Warp Speed, a significant health initiative from the Trump era.
Such a reduction in vaccination numbers could negatively affect Covid-19 vaccine producers Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA).
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.